News/Reuters/EMA committee recommends approval for injectable version of Merck's KeytrudaEMA committee recommends approval for injectable version of Merck's KeytrudaRefinitivLess than 1 min readMRKMerck MRK said on Friday the European Medicines Agency's committee has recommended the approval for a new formulation of its MRK blockbuster cancer therapy Keytruda that can be administered under the skin.North AmericaReutersUS stocks© Copyright Thomson Reuters 2025. Click For Restrictions - https://agency.reuters.com/en/copyright.htmlShow moreLogin or create a forever free account to read this newsLet's go
